Condensed Statement of Stockholders Equity (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Subscription Receivable	Accumulated Deficit
Balance, shares at Dec. 31, 2021		228,667,229
Balance, amount at Dec. 31, 2021	$ (1,141,894)	$ 228,667	$ 71,017,881	$ 0	$ (72,388,442)
Issuance of common stock for services, shares		20,000
Issuance of common stock for services, amount	10,200	$ 20	10,180	0	0
Sale of common stock, shares		184,028
Sale of common stock, amount	77,292	$ 184	77,108	0	0
Common stock issued to settle accounts payable and accrued liabilities, shares		6,252
Common stock issued to settle accounts payable and accrued liabilities, amount	4,001	$ 6	3,995	0	0
Net Loss	(964,264)	$ 0		0	(964,264)
Balance, shares at Mar. 31, 2022		228,877,509
Balance, amount at Mar. 31, 2022	(2,014,665)	$ 228,877	71,109,164	0	(73,352,706)
Balance, shares at Dec. 31, 2022		230,871,034
Balance, amount at Dec. 31, 2022	$ (2,064,927)	$ 230,871	71,830,695	(50,550)	(74,075,943)
Sale of common stock, shares	850,000	2,535,000
Sale of common stock, amount	$ 575,855	$ 2,535	522,770	50,550	0
Net Loss	(1,142,706)	$ 0	0	0	(1,142,706)
Common stock issued to settle accrued liabilities - related party, shares		637,500
Common stock issued to settle accrued liabilities - related party, amount	168,938	$ 638	168,300	0	0
Common stock issued to settle accrued liabilities, shares		300,000
Common stock issued to settle accrued liabilities, amount	79,500	$ 300	79,200	0	0
Common stock issued for a stock subscription receivable, shares		400,000
Common stock issued for a stock subscription receivable, amount	0	$ 400	71,317	(71,717)	0
Amortization of deferred offering costs	$ (55,371)	$ 0	(55,371)	0	0
Common stock issued for litigation settlement, shares	1,850,000	1,850,000
Common stock issued for litigation settlement, amount	$ 462,500	$ 1,850	460,650	0	0
Balance, shares at Mar. 31, 2023		236,593,534
Balance, amount at Mar. 31, 2023	$ (1,976,211)	$ 236,594	$ 73,077,561	$ (71,717)	$ (75,218,649)